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INTRODUCTION
Although pain is a common presentation in emergency 
departments (EDs),(1) lack of pain control or ‘oligoanalgesia’ 
frequently occurs.(2) In a crowded ED, time to analgesia is often 
prolonged(3) and this can be detrimental, as the quality of pain 
management affects patient outcomes.
One of the factors that improves the timing of pain management 
is the route of analgesia administration. Occasionally, clinicians 
may have difficulty in establishing an intravenous line, resulting 
in a delay in drug administration. Administering analgesia via the 
intranasal route has recently been advocated as an alternative 
method to overcome the problem of delayed drug administration.(4) 
In properly selected patients, use of the intranasal route reduces 
the time from drug administration to the onset of drug action. It 
can also help to alleviate manpower constraints and eliminate 
needlestick exposure risk and injection pain, compared to drug 
administration via injections.(5) The intranasal route enables rapid 
absorption of the administered drug because the nasal mucosa is 
highly vascularised; only two cell layers separate the nasal lumen 
from the nasal mucosa’s blood vascular system.(6) Furthermore, 
this route affords a large surface area (150–180 m2)(7) for drug 
delivery and eliminates first-pass metabolism,(8) allowing the 
drug to enter the cerebrospinal fluid via the olfactory mucosa for 
immediate therapeutic effect.(9) For example, intranasal fentanyl 
has been shown to achieve therapeutic serum levels within two 
minutes of administration.(10)
Tramadol, a synthetic opioid of the aminocyclohexanol 
group, has been shown to possess an analgesic potency equivalent 
to that of pethidine.(11) Fentanyl is a synthetic phenylpiperidine 
derivative whose analgesic potency is 50–80 times that of 
morphine.(12) Fentanyl also has a rapid onset of action (within 
6–8 minutes following intranasal administration) due to its high 
lipid solubility.(13) Studies conducted in prehospital settings 
have shown that intranasal fentanyl is as effective an analgesic 
as intravenous morphine in adult(14) and paediatric patients.(15)
Although the evidence regarding the use of intranasal fentanyl 
in EDs is limited, the few published studies show promising results. 
In one study, intranasal fentanyl was shown to be as effective an 
analgesic as intramuscular morphine in children presenting to 
the ED.(16) In another study conducted in an ED setting, intranasal 
fentanyl was shown to be comparable to intravenous morphine 
in reducing pain in a paediatric population that had acute long 
bone fractures.(17) Yet another study showed that it provides 
effective analgesia for paediatric patients with painful orthopaedic 
traumas.(18) While the use of intranasal fentanyl in the ED has 
been shown to be effective in paediatric populations,(9) there are 
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INTRODUCTION The use of intranasal fentanyl as an alternative type of analgesia has been shown to be effective in 
paediatric populations and prehospital settings. There are a limited number of studies on the use of intranasal fentanyl 
in adult patients in emergency settings.
METHODS An open-label study was conducted to evaluate the effectiveness of the addition of 1.5 mcg/kg intranasal 
fentanyl to 2 mg/kg intravenous tramadol (fentanyl + tramadol arm, n = 10) as compared to the administration of 2 mg/kg 
intravenous tramadol alone (tramadol-only arm, n = 10) in adult patients with moderate to severe pain due to acute 
musculoskeletal injuries.
RESULTS When analysed using the independent t -test, the difference between the mean visual analogue scale scores 
pre-intervention and ten minutes post-intervention was 29.8 ± 8.4 mm in the fentanyl + tramadol arm and 19.6 ± 9.7 mm 
in the tramadol-only arm (t[18] = 2.515, p = 0.022, 95% confidence interval 1.68–18.72 mm). A statistically significant, 
albeit transient, reduction in the ten-minute post-intervention mean arterial pressure was noted in the fentanyl + tramadol 
arm as compared to the tramadol-only arm (13.35 mmHg vs. 7.65 mmHg; using Mann-Whitney U test with U-value 21.5, 
p = 0.029, r = 0.48). There was a higher incidence of transient dizziness ten minutes after intervention among the patients 
in the fentanyl + tramadol arm.
CONCLUSION Although effective, intranasal fentanyl may not be appropriate for routine use in adult patients, as it could 
result in a significant reduction in blood pressure.
Keywords: fentanyl, intranasal drug administration, tramadol
